Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at the ESC Congress 2015

PhilipsRoyal Philips (NYSE: PHG AEX: PHIA) today announced its presence at the ESC Congress 2015, where the company is showcasing its latest cardiology solutions, including Heart ModelA.I., EchoNavigator and IntelliSpace Cardiovascular, that connect people and technology with care protocols to assist diagnosis, guide treatment and enable home care.

Visitors to the Philips booth (#G200) will experience Philips’ holistic approach to cardiovascular care, featuring its best in class digital tools and capabilities for image guided therapy and ultrasound, intravascular imaging and sensing, treatment, patient monitoring, healthcare IT and advanced software applications driving advancements in predictive and precision medicine in cardiovascular care.

"Holistic cardiovascular care looks beyond the disease to understand what really matters for all involved along the patient journey," said Bert van Meurs, General Manager, Image Guided Therapy for Philips. "Our patient-centric solutions enable novel and effective minimally invasive procedures to diagnose and treat cardiovascular disease. These solutions also support physicians when assessing disease states, help decide and guide the right treatment and confirm whether interventions were successful. In addition, our recent acquisition of Volcano will increase our capabilities to deliver this support to both physicians and patients."

The ESC Congress 2015 is the largest and most influential cardiology event in the world, and will showcase the industry's most promising research and leading innovations. Throughout the event, Philips and their physician partners will participate in several Satellite Symposia and hands-on tutorials on topics including anatomical intelligence and peri-interventional imaging, discussing the latest advances in diagnostic and interventional echo.

Philips' newest ultrasound technology cardiac tool, HeartModelA.I., which brings automated 3D views, robust reproducibility and advanced quantification to cardiac ultrasound imaging, will make its European debut at the Philips Booth (#G200). Philips will also offer demonstrations at the booth of its advanced imaging and ultrasound solutions designed for every step of the patient journey, including:

Delivering More Confident Decision-Making

  • HeartModel - part of a suite of new tools and technologies available on Philips' EPIQ Ultrasound system designed to enhance automation and reproducibility, and helps to address some of the most critical strains on overburdened hospitals and healthcare systems challenged to provide higher quality care at lower costs
  • IntelliSpace Cardiovascular - this workspace gives access to the full range of images and includes a cardiac history timeline to provide a comprehensive overview of the patients' care along the health continuum
  • Minicare 1-20 Acute* - A user-friendly handheld point-of-care blood testing platform that speeds up clinical diagnosis by providing results within minutes

Guiding the Optimal Treatment Path

  • EchoNavigator - Fuses live 3D TEE and X-ray in real time to provide image guidance in the 3D space, supporting physicians in complex structural heart procedures to decide, guide and confirm the optimal treatment path, enabling better patient outcomes and more cost effective care
  • AlluraClarity - simplifies procedures and improves workflow, while delivering excellent image quality at a lower dose
  • Volcano IVUS (intravascular ultrasound) - provides detailed and accurate measurements of the vessel and over a wide range of clinical studies has been shown to help ensure accurate stent expansion and apposition and a reduced need for x-ray imaging
  • Volcano iFR Scout™ - pullback technology that reveals the physiologic profile of the entire vessel and is optimized to assess serial lesions and diffuse coronary disease enabling physicians to make informed treatment decisions.

* Minicare is still under development and not yet available for sale

Related news articles:

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2014 sales of EUR 21.4 billion and employs approximately 108,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

Most Popular Now

Oracle Buys Cerner

Oracle Corporation (NYSE: ORCL) and Cerner Corporation jointly announced an agreement for Oracle to acquire Cerner through an all-cash tender offer for $95.00 per share, or approximately $28.3 billion in...

Philips and IJsselland Hospital Sign Lon…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has signed a 12-year strategic partnership with IJsselland Hospital (Capelle aan den Ijssel, The Netherlands)...

Computer Programs and Mobile Apps may He…

The COVID-19 pandemic has had a major impact on mental health across the globe. Depression is predicted to be the leading cause of lost life years due to illness by...

AI Points the Way to Better Doctor-Patie…

A computer analysis of hundreds of thousands of secure email messages between doctors and patients found that most doctors use language that is too complex for their patients to understand...

Could EKGs Help Doctors use AI to Detect…

Pulmonary embolisms are dangerous, lung-clogging blot clots. In a pilot study, scientists at the Icahn School of Medicine at Mount Sinai showed for the first time that artificial intelligence (AI)...

Mayo Clinic Researchers Use AI, Biomarke…

Treatment options for rheumatoid arthritis have often relied on trial and error. Now Mayo Clinic researchers are exploring the use of artificial intelligence (AI) and pharmacogenomics to predict how patients...

Open Call DIGITAL-2021-DEPLOY-01-TWINS-H…

The development of digital twins in healthcare (DTH) has progressed substantially, profiting from advances in science and technology. In order to exploit their benefits in view of better prevention approaches...

Computer Model of Blood Enzyme

Membrane-associated proteins play a vital role in a variety of cellular processes, yet little is known about the membrane-association mechanism. Lipoprotein-associated phospholipase A2 (Lp-PLA2) is one such protein with an...

Mjog by Livi Launches Remote Monitoring …

Mjog by Livi has launched a remote monitoring tool that will help GPs support and monitor people with depression through messages sent to their smartphones. The latest data from the Office...

4.5 Million Euros in EU Funding for Saar…

This year, three computer scientists from Saarbrücken were awarded an "ERC Starting Grant" by the European Research Council. This award, endowed with 1.5 million euros each, is among the most...

2022 EU4Health Work Programme Adopted to…

Today the Commission has adopted the second EU4Health work programme. In 2022, the EU4Health will continue to invest in building stronger, more resilient health systems and pave the way for...

Five NHS Trusts in Surrey and Sussex to …

A consortium of NHS trusts that covers a population of circa 1.2 million will gain immediate access to important patient imaging, and will mobilise a regional workforce for patients, following...